Literature DB >> 18282543

Ocular allergy overview.

Leonard Bielory1.   

Abstract

The prevalence of ocular allergy clearly is underappreciated and has been under diagnosed and undertreated. The ocular symptoms associated with the most common ocular allergy conditions, such as seasonal and perennial allergic conjunctivitis, are twice as likely to affect the allergy sufferer rather than nasal symptoms alone. The differential diagnosis of conjunctivitis is quite broad, with the most common forms associated with allergies, infections, and hormones. There are common features and some discerning features that, with a good history and examination, may provide a more focused and appropriate management.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18282543     DOI: 10.1016/j.iac.2007.12.011

Source DB:  PubMed          Journal:  Immunol Allergy Clin North Am        ISSN: 0889-8561            Impact factor:   3.479


  20 in total

1.  Allergic conjunctivitis and nasal allergy.

Authors:  Zdenek Pelikan
Journal:  Curr Allergy Asthma Rep       Date:  2010-07       Impact factor: 4.806

2.  The management of ocular allergy in community pharmacies in the United Kingdom.

Authors:  Paramdeep Bilkhu; James S Wolffsohn; Deanna Taylor; Emma Gibson; Bhavik Hirani; Shehzad A Naroo
Journal:  Int J Clin Pharm       Date:  2013-01-01

3.  Increased red cell distribution width levels in children with seasonal allergic conjunctivitis.

Authors:  Bengi Ece Kurtul; Emrah Utku Kabatas; Songul Deniz Boybeyi; Ayla Akca Caglar; Pinar Altiaylik Ozer
Journal:  Int Ophthalmol       Date:  2017-05-18       Impact factor: 2.031

4.  Management of allergic conjunctivitis: an evaluation of the perceived comfort and therapeutic efficacy of olopatadine 0.2% and azelastine 0.05% from two prospective studies.

Authors:  Arthur B Epstein; Peter T Van Hoven; Alan Kaufman; Warner W Carr
Journal:  Clin Ophthalmol       Date:  2009-06-02

5.  Density-equalizing mapping and scientometric benchmarking of European allergy research.

Authors:  Cristian Scutaru; David Quarcoo; Mohannad Sakr; Awfa Shami; Khaled Al-Mutawakel; Karin Vitzthum; Tanja C Fischer; Torsten Zuberbier; Beatrix Groneberg-Kloft
Journal:  J Occup Med Toxicol       Date:  2010-02-16       Impact factor: 2.646

6.  Intranasal corticosteroids: do they improve ocular allergy?

Authors:  Catherine Origlieri; Leonard Bielory
Journal:  Curr Allergy Asthma Rep       Date:  2009-07       Impact factor: 4.806

7.  TSLP and downstream molecules in experimental mouse allergic conjunctivitis.

Authors:  Xiaofen Zheng; Ping Ma; Cintia S de Paiva; Matthew A Cunningham; Cindy S Hwang; Stephen C Pflugfelder; De-Quan Li
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-01-27       Impact factor: 4.799

8.  Effect of alcaftadine 0.25% on ocular itch associated with seasonal or perennial allergic conjunctivitis: a pooled analysis of two multicenter randomized clinical trials.

Authors:  Joseph B Ciolino; Eugene B McLaurin; Nicholas P Marsico; Stacey L Ackerman; Julia M Williams; Linda Villanueva; David A Hollander
Journal:  Clin Ophthalmol       Date:  2015-05-02

9.  Comparative efficacy of bepotastine besilate 1.5% ophthalmic solution versus olopatadine hydrochloride 0.2% ophthalmic solution evaluated by patient preference.

Authors:  Craig F McCabe; Shannon E McCabe
Journal:  Clin Ophthalmol       Date:  2012-10-29

10.  Steroid-induced ocular hypertension in Asian children with severe vernal keratoconjunctivitis.

Authors:  Marcus Ang; Seng-Ei Ti; Raymond Loh; Sonal Farzavandi; Rongli Zhang; Donald Tan; Cordelia Chan
Journal:  Clin Ophthalmol       Date:  2012-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.